Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2021; 09(03): E470-E471
DOI: 10.1055/a-1339-1089
Editorial

Stop taking routine biopsy specimens for the diagnose of a duodenal adenoma!

Autoren

  • Yasushi Yamasaki

    1   Department of Gastroenterology, Okayama University Hospital, Okayama, Japan
  • Noriya Uedo

    2   Department of Gastrointestinal oncology, Osaka International Cancer Institute, Osaka, Japan

10.1055/a-1293-7487Non-ampullary duodenal adenomas are relatively rare in the general population compared to other gastrointestinal neoplasms [1]; however, because they are considered precancerous, early detection and treatment are desirable [2] [3]. Recently, because of advances in endoscopic technology, the opportunities for endoscopic detection and treatment of non-ampullary duodenal adenomas in clinical practice has increased. Endoscopic resection (ER) has been a first choice for treatment of non-ampullary duodenal adenomas, but the incidence of adverse events (AEs) such as immediate/delayed perforation and bleeding is not negligible [4]. Besides the conventional injection endoscopic mucosal resection (EMR) technique, several ER techniques, such as cold snare polypectomy (CSP), underwater endoscopic mucosal resection (UEMR), endoscopic submucosal dissection (ESD) with complete closure and laparoscopy-endoscopy cooperative surgery (LECS) have been developed to prevent AEs and are available [5].



Publikationsverlauf

Artikel online veröffentlicht:
19. Februar 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany